Creative Medical Technology Holdings, Inc. (CELZ) vs Heatwurx Inc. (PCSA)

Creative Medical Technology Holdings, Inc. and Heatwurx Inc. are both Biotechnology companies. Creative Medical Technology Holdings, Inc. and Heatwurx Inc. are of similar size ($5.2M and $5.1M). Creative Medical Technology Holdings, Inc. has negative trailing earnings, so its P/E is not meaningful; Heatwurx Inc. trades at 1.8×. Heatwurx Inc. grew revenue faster over the last twelve months: −34.5% against −79.4%. Across the 11 metrics below, Heatwurx Inc. leads on 6 and Creative Medical Technology Holdings, Inc. on 5.

Valuation

Metric CELZ PCSA Biotechnology median
P/E n/m 1.75 8.58
P/S 165.49 38.64 10.29
P/B 0.32 n/m 2.29
Price to free cash flow n/m n/m 21.93
EV/EBITDA 0.96 n/m 0.67
EV/Sales (347.51) 48.44 9.89
Earnings yield (272.37%) 57.14% (31.56%)
Free cash flow yield (398.93%) (259.68%) (23.42%)

Profitability

Metric CELZ PCSA Biotechnology median
Gross margin 61.18% 0.00% 65.77%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (77.91%) (464.19%) (54.09%)
Return on assets (73.30%) (262.17%) (47.78%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CELZ PCSA Biotechnology median
Revenue growth (TTM) (79.42%) (34.50%) 5.83%
EPS growth (last fiscal year) 32.08% 89.29% 29.36%
Revenue growth, 5-year CAGR (48.43%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CELZ PCSA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 12.91 0.87 4.80
Net debt to EBITDA 1.20 0.40 0.97

Dividend

Metric CELZ PCSA Biotechnology median
Dividend yield — — 0.44%
Payout ratio — — —

Size

Metric CELZ PCSA Biotechnology median
Market cap 5.10m 5.20m 153.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack